Citadel Advisors »

Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by Citadel Advisors

Quarter-by-quarter ownership of Mirum Pharmaceuticals Inc Note 4.000 5/0 shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Mirum Pharmaceuticals Inc Note 4.000 5/0

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals Inc Note 4.000 5/0 held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals Inc Note 4.000 5/0 by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $59M 24M 2.41
2025-06-30 $40M 22M 1.78
2025-03-31 $29M 18M 1.63

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0

Deerfield Management Company
Readystate Asset Management
MacKay Shields
Tenor Capital Management
Citadel Advisors
Franklin Resources
Polar Securities
Capstone Investment Advisors
Bnp Paribas Arbitrage, Snc
Point72 Asset Management
FMR
Aristeia Capital
Aequim Alternative Investments
SSI Investment Management
Lord, Abbett & Co

View all funds holding Mirum Pharmaceuticals Inc Note 4.000 5/0